Sign in to view content

Phase 1/2 Clinical Trial of Intravitreal 4D-125 AAV Gene Therapy in Patients with Advanced XLRP: Interim Safety & Preliminary Activity

Cagri G Besirli, MD, PhD, FASRS

Video
Published 2021

Related

Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II ALTITUDE Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2022
AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: 6-month Results From a Phase 1/2 Clinical Trial
Michel Michaelides, BSc, MB BS, MD(Res), FRCOphth, FACS
Updates from the Field
2020
Pericentral Retinitis Pigmentosa
Mauricio Bayram-Suverza, MD
Mark E Pennesi, MD/PhD
Retina Image Bank: Images of the Week
2024

Category: Hereditary Retinal Disease & Genetics

See more